Epithalon
Epithalon (Epitalon)
Potential Benefits
- Preclinical research suggests activation of telomerase in human somatic cells
- Animal studies indicate potential for extending lifespan in certain models
- May support regulation of the neuroendocrine system
- Research suggests possible normalization of melatonin production in aging individuals
- Animal data indicates potential antioxidant effects
Recommended Starting Dose
5-10 mg subcutaneously or intravenously per day during active cycles
Based on published research protocols. Not a prescription.
Dosing Protocol
A common protocol involves 5-10 mg injected once daily for 10-20 consecutive days, repeated every 4-6 months. Some protocols use 10 mg every other day for 20 days. Most data comes from Khavinson's research group in Russia.
DOSING INFORMATION DISCLAIMER: Any dosing information, protocols, or ranges discussed on this site are drawn from published research studies and clinical literature. They are presented for educational reference only and must not be used as self-medication guidance.
Expected Timeline
Phase 1
Biomarker changes (if any) may take several months to measure. Subjective reports of improved sleep and energy vary widely. Anti-aging benefits, if they exist, would require long-term assessment.
Research Status
The regulatory status of peptides can change at any time. Verify current FDA classification and legal status in your jurisdiction before seeking medical consultation about this compound.
Potential Side Effects
- Very limited human safety data
- Injection site reactions possible
- Theoretical concerns about telomerase activation in cancerous cells (not confirmed in studies)
- Possible effects on sleep patterns due to melatonin modulation
- Long-term safety profile is unknown
More in Anti-Aging
GHK-Cu
Copper Peptide GHK-Cu
GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) found in human plasma, saliva, and urine. Its concentration declines with age. Research suggests it plays roles in wound healing, collagen synthesis, and gene expression modulation. It is widely used in topical skincare and studied for systemic anti-aging applications.
MOTS-c
Mitochondrial Open Reading Frame of the 12S rRNA-c
MOTS-c is a mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA gene. Discovered in 2015 by Dr. Pinchas Cohen's lab at USC, it is the first known mitochondrial-encoded peptide that acts as a hormone. Research suggests it plays a role in metabolic homeostasis, exercise mimicry, and cellular stress resistance.
HN
Humanin
Humanin is a mitochondrial-derived peptide consisting of 24 amino acids, first identified in 2001 from surviving neurons of Alzheimer's disease patients. It is encoded in the mitochondrial genome within the 16S ribosomal RNA gene. Research has focused on its cytoprotective, neuroprotective, and metabolic regulatory properties.
Medical Disclaimer
EDUCATIONAL CONTENT ONLY: The peptide information presented on this page is compiled from published scientific literature, peer-reviewed research, and publicly available clinical data. It is provided strictly for educational purposes and does not constitute medical advice, an endorsement of any specific peptide, or a recommendation for treatment. Many peptides discussed on this site have not received FDA approval for human therapeutic use. Some may be under active regulatory review or subject to restrictions on compounding under FDA Section 503A and 503B frameworks. The regulatory status of individual peptides can change at any time. Readers should verify the current legal status of any peptide in their jurisdiction before pursuing further information or consultation. If you are considering peptide therapy, seek guidance from a licensed physician or healthcare provider who specializes in peptide-based treatments and operates within applicable federal and state regulations.